Navigation Links
Wyeth and Impax Announce Final Settlement of Effexor XR Patent Suit
Date:7/16/2008

-- Federal Court Enters Consent Judgment Terminating Litigation --

MADISON, N.J., July 16 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WYE) and Impax Laboratories Inc. today announced that all conditions of a settlement of the U.S. patent infringement litigation pertaining to Impax's proposed generic capsule formulation of Wyeth's EFFEXOR XR(R) antidepressant have been approved by the United States District Court for the District of Delaware. The Court entered a consent judgment resulting in termination of the litigation effective today.

Under the terms of the settlement, Wyeth has granted Impax a license that would permit Impax to launch its capsule formulation of Effexor XR on or after June 1, 2011, subject to earlier launch in limited circumstances, but in no event earlier than January 1, 2011. Impax will pay Wyeth a royalty on sales of this generic product.

The parties also have agreed that Impax will utilize its neurology-focused sales force to promote a product to be named by Wyeth. Other terms of this agreement are confidential and were not disclosed.

Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology products, nutritionals and non-prescription medicines that improve the quality of life for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.

The statements in this press release that are not historical facts are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed o
'/>"/>

SOURCE Wyeth
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Wyeths Motion to Overturn Punitive Damages Award Granted by Arkansas Court
2. Wyeth Announces Bernard Poussot Assumes Chairman of the Board Position
3. Wyeth Declares Common and Preferred Stock Dividends
4. Wyeth Pharmaceuticals Announces Organizational Change
5. Intellect Neurosciences, Inc. Grants License for Certain Patents and Patent Applications to Wyeth and Elan Pharma International Ltd.
6. Wyeth to Present at the 2008 Citi Investment Research Global Healthcare Conference
7. Wyeth Research Head Robert R. Ruffolo, Jr., Ph.D., Announces Retirement
8. Wyeth Chairman Robert Essner Announces June 27 Retirement
9. Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness Patients
10. Wyeth to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference
11. Wyeth Sets Webcast And Conference Call For 2008 First Quarter Earnings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... Global Stem Cells Group ... plans to conduct Turkey’s first ever stem cell harvesting ... his alliance with Stem Cell Training, Inc. and in ... Tiryaki, M.D. will conduct the Adipose and Bone ... Istanbul. , Tiryaki, a renowned plastic surgeon practicing in ...
(Date:6/3/2015)... 02, 2015 Research and Markets ... of the "2015 Strategies in the ... to their offering. This new ... immunoprotein diagnostic market, including emerging tests, technologies, ... profiles of leading suppliers. During ...
(Date:6/3/2015)... HOLLYWOOD, Calif. , June 3, 2015 ... of life of myeloma patients while working toward prevention ... Annual International Myeloma Working Group (IMWG) Summit June ... record 100-plus IMWG members will attend the 2015 Summit, ... of the European Hematology Association (EHA).  The focus of ...
(Date:6/3/2015)... 2015 Findings presented at the ... European Association of NeuroOncology (EANO) and European Society for ... demonstrate that EDO-S101 is effective in models of ... combination with radiotherapy (RT). [ 1 ] ... fusion molecule that combines the DNA damaging effect of ...
Breaking Biology Technology:Global Stem Cells Group subsidiary Stem Cell Training Announces First Training Course to Take Place in Turkey 2Global Stem Cells Group subsidiary Stem Cell Training Announces First Training Course to Take Place in Turkey 3United States Strategies in the Immunoprotein Diagnostic Testing Market Report 2015 2International Myeloma Foundation Brings Together 100 of the World's Top Myeloma Experts June 8-10 in Vienna, Austria for 6th Annual Summit 2International Myeloma Foundation Brings Together 100 of the World's Top Myeloma Experts June 8-10 in Vienna, Austria for 6th Annual Summit 3International Myeloma Foundation Brings Together 100 of the World's Top Myeloma Experts June 8-10 in Vienna, Austria for 6th Annual Summit 4Mundipharma EDO GmbH Data Confirm EDO-S101 is Effective in Preclinical Models of Human Glioblastoma 2Mundipharma EDO GmbH Data Confirm EDO-S101 is Effective in Preclinical Models of Human Glioblastoma 3Mundipharma EDO GmbH Data Confirm EDO-S101 is Effective in Preclinical Models of Human Glioblastoma 4
... Today at 5:00 p.m. EDT -, VALENCIA, Calif., ... reported financial results for the first quarter ended,March 31, ... operating expenses were $74.1,million, compared to $77.3 million for ... decreased by $5.3 million to $58.4 million,for the first ...
... Inc. (Nasdaq:,BIOD) today announced that Gerard Michel, Chief Financial ... will present a,corporate update at the Bank of America ... a.m. Pacific Time (12:20 p.m. ET). The conference will,be ... Nevada., Interested parties may access a link to ...
... who helped,explain how embryos develop and form limbs, the ... 2008 March of Dimes Prize in Developmental,Biology., Philip ... share the 2008,March of Dimes Prize for their pioneering ... and their protein signals guide the,formation of the brain, ...
Cached Biology Technology:MannKind Corporation Reports First Quarter Financial Results 2MannKind Corporation Reports First Quarter Financial Results 3MannKind Corporation Reports First Quarter Financial Results 4March of Dimes Awards $250,000 Prize to Leaders in Understanding Embryonic Development 2March of Dimes Awards $250,000 Prize to Leaders in Understanding Embryonic Development 3
(Date:5/14/2015)... and Markets ( http://www.researchandmarkets.com/research/5whpxg/fingerprint ) has announced ... Smart Mobile Devices " report to their offering. ... watershed year for fingerprint sensors in smartphones and tablets, ... fingerprint sensors a raison d,etre in the mobile milieu ... must-have feature in flagship smartphones. The key ...
(Date:5/11/2015)... N.Y. , May 11, 2015 Curemark ... announced the start of a new Phase III double ... of its novel formulation, CM-AT, on all children ages ... of its FDA Phase III double blinded clinical trial ... had low levels of the digestive enzyme chymotrypsin. This ...
(Date:5/6/2015)... LifeBEAM, a developer of bio-sensing technology, and ... that they will expand their partnership in bio-sensing sports ... helmet and the first joint project between the two ... order to give cyclists more style choices and meet ... Lazer announced their plan to release a new generation ...
Breaking Biology News(10 mins):Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3
... GAINESVILLE, Fla. Survival of the fittest has popularly ... new study published in the Royal Society journal Biology ... millions of years may also play a powerful role. ... are the first to link the evolution of proteins ...
... Emory University School of Medicine a three-year grant of more ... that may contribute to the development of autism. Stephen ... Genetics, is principal investigator of the program project that also ... faculty members in human genetics. Autism occurs four ...
... research project, which receives funding from Hope Against ... an extract from bilberries can prevent or delay ... Gescher, of the University of Leicester, is ... with the commercially produced substance Mirtoselect (extracted from ...
Cached Biology News:UF researchers devise way to calculate rates of evolution 2UF researchers devise way to calculate rates of evolution 3Simons Foundation awards Emory scientists $3M for autism gene research 2Bilberry extract -- can it help prevent certain cancers? 2Bilberry extract -- can it help prevent certain cancers? 3
... Xylene Resistant (X/R) Red System consists ... Red Activator and X/R Red Buffer. ... alkaline phosphatase to produce red staining ... ,Kit Contains:, , Buffer, 100 mL ...
Phospho-YAP (Ser127) Antibody Ship: Hot Store: -20 C...
Mouse Cell Line Slides...
... comprehensive, cost-effective solution to your TechMate ... quality into both our products and ... chemistries and antibodies that have been ... also includes our competitively priced accessories ...
Biology Products: